Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
neurological disorders
Biotech
Addex stock rises after Indivior offers up to $300M for compound
Indivior is picking up Addex's compound designed to treat substance use disorder, giving the Swiss biotech the chance to make up to $300 million.
Gabrielle Masson
Aug 27, 2024 10:50am
NeuroOne nabs nod for brain monitoring and ablation system
Dec 11, 2023 11:42am
Pharnext blames ‘unexpected’ placebo results for phase 3 failure
Dec 11, 2023 9:18am
Jazz puts up $771M to form Autifony neuroscience discovery pact
Nov 14, 2023 9:40am
Beacon beams up FDA nod for AI-powered sleep monitoring headset
Sep 15, 2023 10:27am
Eli Lilly-backed Nido Biosciences unveils with $109M
May 15, 2023 7:15am
